FIELD: medicine.
SUBSTANCE: cardiac hystiocytes are proliferated by inducing of cyclin and CDK expression in cardiac hystiocytes and by inhibiting function or activity of protein of Cip/Kip family or by inhibiting production of protein of Cip/Kip family. There is described expression vector that contains a cyclin gene, a cyclin-dependent kinase gene and one or several agents chosen from the group consisting of a gene coding the factor which inhibits production, function or activity of protein of Cip/Kip family and nucleic acid sequence which inhibits production of protein of Cip/Kip family. There is disclosed pharmaceutical composition containing said vector, and applied for treatment of cardiac diseases. There is offered cardiac hystiocyte produced by the declared method. There is presented method of treating a cardiac disease that implies injection of the disclosed pharmaceutical composition.
EFFECT: regeneration and recovery of cardiac hystiocytes.
31 cl, 13 dwg, 1 tbl, 6 ex
Title |
Year |
Author |
Number |
TREATMENT OF TUMORS WITH A COMBINATION OF ONCOLYTIC ADENOVIRUS AND CDK4/6 INHIBITOR |
2019 |
- Holm, Per, Sonne
- Nawroth, Roman
|
RU2811278C2 |
METHOD OF STEM CELLS DIFFERENTIATION INTO MIOCARDIAL CELLS INDUCTION |
2004 |
- Fukuda Kejiti
- Juasa Sinsuke
- Okano Khidejuki
- Simazaki Takuja
- Kosimizu Uiti
- Tanaka Tomofumi
- Sugimura Kejdziro
|
RU2392315C2 |
IDENTIFICATION AND APPLICATION OF MUTANTIAL KRP IN PLANTS |
2012 |
- Olivier Jean Paul
- Loeffler Dayna L.
|
RU2631790C2 |
TREATING TUMORS WITH COMBINATION OF ONCOLYTIC ADENOVIRUS, CDK4/6 INHIBITOR AND ADDITIONAL THERAPEUTIC AGENT |
2020 |
- Holm, Per Sonne
- Nawroth, Roman
|
RU2835886C1 |
COMBINATION INCLUDING CYCLIN-DEPENDENT KINASE 4 INHIBITOR OR CYCLIN-DEPENDENT KINASE 6 INHIBITOR (CDK4/6) AND mTOR INHIBITOR FOR TREATING CANCER |
2011 |
- Borland Mariya
- Brejn Kristofer Tomas
- Doshi Shivang
- Kim Sunkiu
- Ma Tszyango
- Merti Dzhosh
- Chzhan Khun
|
RU2589696C2 |
6,9-DISUBSTITUTED 2-[TRANS-(4-AMINOCYCLOHEXYL)-AMINO]PURINES |
1999 |
- Djumon Dzhennifer A.
- Bitonti Alan Dzh.
- Borcherding Dehvid R.
- Pit Norton P.
- Manson Kh. Rehndehll
- Sham Patrik V.K.
|
RU2191777C2 |
PHARMACEUTICAL COMBINATIONS OF CDK4/6 INHIBITOR AND B-Raf INHIBITOR |
2013 |
- Kaponigro Dzhordano
- Styuart Darrin
- Kim Sunkiu
- Loo Elis
- Delech Skott
|
RU2685250C2 |
MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE |
1995 |
|
RU2164419C2 |
AGENT INDUCING CELL DEATH, CELL GROWTH INHIBITING AGENT, AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASE CAUSED BY ABNORMAL CELL GROWTH |
2015 |
- Niitsu Yoshiro
- Minomi Kenjirou
- Tanaka Hiroyuki
|
RU2707746C2 |
MUTATIONS OF MTS GENE IN EMBRYONIC LINE AND METHOD OF DETECTION OF PREDISPOSITION TO MALIGNANT TUMORS |
1995 |
- Skol'Nik Mark Kh.
- Kennon-Ehlbrajt Lajza A.
- Kehmb Aleksandr
|
RU2161309C2 |